Zafirlukast (AvPAK)


Welcome to the PulseAid listing for the Zafirlukast drug offered from AvPAK. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AvPAK
NON-PROPRIETARY NAME: Zafirlukast
SUBSTANCE NAME: ZAFIRLUKAST
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-09-15
END MARKETING DATE: 0000-00-00


Zafirlukast HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZafirlukast from AvPAK
LABELER NAME: AvPAK
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2017-09-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50268-805_c063565a-bf48-4941-9db5-aff7b39412c7
PRODUCT NDC: 50268-805
APPLICATION NUMBER: ANDA090372

Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingZafirlukast
AstraZeneca Pharmaceuticals LPACCOLATE
Avera McKennan HospitalZafirlukast
AvPAKZafirlukast
Carilion Materials ManagementZafirlukast
Dr. Reddys Laboratories LimitedZafirlukast
Par Pharmaceutical Inc.ZAFIRLUKAST
State of Florida DOH Central PharmacyACCOLATE